 |
|
|
| |
Obeticholic Acid Demonstrates Sustained Improvements at Month 24 in Transaminases and Non-invasive Markers of Fibrosis: Results of a Post Hoc Analysis From the Interim Analysis of the REGENERATE Study
|
| |
| |
EASL 2020 Aug 27-29
Reported by Jules Levin
Rohit Loomba,1 Vlad Ratziu,2 Quentin M. Anstee,3 Stephen Harr ison,4 Arun J. Sanyal,5 Mary Rinell a,6 Zobair M. Younossi,7 Zachary Goodman,7 Pierr e Bedossa,8
Reshma Shringarpure,9 Huafeng Zhou,9 Aditya Venugopal,9 Mazen Noureddin10
1University of California, San Diego, San Diego, CA, USA; 2Sorbonne Universite, Hopital Pitie-Salpetriere, Paris, France; 3Translational & Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom;
4Pinnacle Clinical Research Center, San Antonio, TX, USA; 5Virginia Commonwealth University, Richmond, VA, USA; 6Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; 7Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, USA;
8Service d'Anatomie Pathologique, Hopital Beaujon, Assistance Publique-Hopitaux de Paris, Paris, France; 9Intercept Pharmaceuticals, San Diego, CA, USA; 10Cedars-Sinai Medical Center, Los Angeles, CA, USA
|
| |
|
|
|
|
|
